Pancreatic Cancer Research

ResearcherUniversity of RochesterActive in the last 2 years

Brian James Altman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3954-4916; OpenAlex author ID A5079265940; NIH RePORTER profile ID 11479021. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
1
Labs led
0
Collaborators
12
Papers, trials and grants by year

2026: 1 paper, 1 grant

Papers 1

  1. The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion. Co-author DOI 10.1016/j.devcel.2026.04.001↗

Grants 1

  1. The role of circadian gene regulation in pancreatic cancer progression and immune evasion U01CA313692↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paula M. Vertino · 1 shared paper, 1 shared grant, 2026 · strength 1.20
  2. Darren R. Carpizo · 1 shared paper, 1 shared grant, 2026 · strength 1.20
  3. Lan Wang · 1 shared paper, 2026 · strength 0.20
  4. Anna Bianchi · 1 shared paper, 2026 · strength 0.20
  5. Crissy Dudgeon · 1 shared paper, 2026 · strength 0.20
  6. Jean L. Grem · 1 shared paper, 2026 · strength 0.20
  7. Subhajyoti De · 1 shared paper, 2026 · strength 0.20
  8. Anthony Casabianca · 1 shared paper, 2026 · strength 0.20
  9. Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.20
  10. Paul M. Grandgenett · 1 shared paper, 2026 · strength 0.20
  11. Brian B. Haab · 1 shared paper, 2026 · strength 0.20
  12. Jashodeep Datta · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.